As the new U.S. presidency takes hold and the effects of the COVID-19 pandemic linger, public health has become the center of significant policy shifts and nationwide debates.
President Donald Trump withdrew the U.S. from the World Health Organization (WHO) on his second day in office. Robert F. Kennedy Jr., the newly elected Secretary of Health and Human Services, cut Food and Drug Administration funding and staffing, raising concerns and debates about public health.
As secretary, Kennedy oversees the Medicare and Medicaid health insurance programs, the Food and Drug Administration, Centers for Disease Control and Prevention and the National Institutes of Health . During his “Make America Healthy Again” campaign, Kennedy highlighted goals to prioritize chronic diseases like obesity, mental health and substance abuse over infectious diseases, and he pledged to cut $4 billion from health research facilities budgets.
Public Health Club officer Terry Xie (11) offers his perspective on the ongoing risks of infectious disease in the post-COVID environment.
“We just came out of the pandemic, so infectious diseases are as dangerous as potentially ever,” Terry said. “But I also do agree that chronic diseases are often overlooked, especially long COVID. There’s very little research going into that. It’s definitely important to focus on these chronic diseases, but not at the cost of infectious disease research.”
Public Health Club adviser Patrick Kelly worked with the American Public Health Association to create and edit ‘That’s Public Health,’ an explainer series focusing on clear science communication in public health. He acknowledged how chronic diseases currently present a more pressing issue to U.S. citizens than infectious ones, but still stressed the U.S.’s role in helping other, less-developed countries battle outbreaks.
“We are now at the point in the United States where we are lucky enough to die of chronic diseases, as opposed to infectious diseases,” Kelly said. “We have problems in the United States that do not necessarily have the same priorities as the World Health Organization, but infectious disease is still a big deal around the world that affects tons and tons of people.”
Slashes to public health funding have also intensified debate over the future of public health funding. Kennedy has pledged to eliminate 600 positions from the NIH in order to refocus more resources on chronic disease research.
Director of Health Services Debra Nott reflected on the potential future consequences of the NIH mass layoffs.
“We’ll probably do okay with fewer people in NIH until the next big epidemic happens,” Nott said. “Then we won’t be able to scale up fast enough to deal with it responsibly, and that concerns me.”
Kennedy’s layoffs included over 1000 probationary employees from the FDA, drawing criticism for its possible long term consequences. With fewer staff overseeing safety and research, public confidence in public health agencies may decline. A PEW study found that while 87% of Americans trusted scientists at the start of the pandemic, the percentage dropped to 73% after the pandemic.
“The FDA is one of the most important things for American health in general,” Terry said. “One of the core tenets of any sort of government responsibility is making sure that citizens know that they’re safe consuming food in the country. People are a lot less trusting of the CDC, especially with how politicized it has become with all the vaccination misinformation on social media.”
Kelly highlighted the prevalence of misinformation in the digital age and emphasized the importance of relying on well-researched information to guide public understanding.
“People lost some trust in public health institutions during the pandemic,” Kelly said. “A fire hose of information was coming out, but nobody really knew what the quality of that information was. There were reductions of nuance that shouldn’t have happened. However, there is still a purpose to the expertise of public health institutions, and they are worthy of trust.”